DK1229922T3 - Aplidin-behandling af cancere - Google Patents
Aplidin-behandling af cancereInfo
- Publication number
- DK1229922T3 DK1229922T3 DK00976137T DK00976137T DK1229922T3 DK 1229922 T3 DK1229922 T3 DK 1229922T3 DK 00976137 T DK00976137 T DK 00976137T DK 00976137 T DK00976137 T DK 00976137T DK 1229922 T3 DK1229922 T3 DK 1229922T3
- Authority
- DK
- Denmark
- Prior art keywords
- aplidine
- cancers
- treatment
- tumor
- complementing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927006.8A GB9927006D0 (en) | 1999-11-15 | 1999-11-15 | Aplidine treatment of cancers |
GB0005701A GB0005701D0 (en) | 2000-03-09 | 2000-03-09 | Antitumor utility of aplidine |
GB0007639A GB0007639D0 (en) | 2000-03-29 | 2000-03-29 | Antitumour and anti-angiogenic compound |
GB0015496A GB0015496D0 (en) | 2000-06-23 | 2000-06-23 | Antitumour and anti-angiogenic compound |
GB0025209A GB0025209D0 (en) | 2000-10-13 | 2000-10-13 | Treatment of cancers |
PCT/GB2000/004349 WO2001035974A2 (en) | 1999-11-15 | 2000-11-15 | Aplidine treatment of cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1229922T3 true DK1229922T3 (da) | 2007-10-08 |
Family
ID=27515929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00976137T DK1229922T3 (da) | 1999-11-15 | 2000-11-15 | Aplidin-behandling af cancere |
Country Status (27)
Country | Link |
---|---|
US (1) | US20090298752A1 (pl) |
EP (1) | EP1229922B1 (pl) |
JP (1) | JP2003514025A (pl) |
KR (1) | KR100518986B1 (pl) |
CN (1) | CN1423564A (pl) |
AT (1) | ATE363910T1 (pl) |
AU (1) | AU780417B2 (pl) |
BG (1) | BG65381B1 (pl) |
BR (1) | BR0015811A (pl) |
CA (1) | CA2391502A1 (pl) |
CY (1) | CY1106825T1 (pl) |
CZ (1) | CZ302498B6 (pl) |
DE (1) | DE60035120T2 (pl) |
DK (1) | DK1229922T3 (pl) |
ES (1) | ES2288486T3 (pl) |
HK (1) | HK1045648B (pl) |
HU (1) | HUP0203906A2 (pl) |
IL (1) | IL149488A0 (pl) |
MX (1) | MXPA02004862A (pl) |
NO (1) | NO330719B1 (pl) |
NZ (1) | NZ518847A (pl) |
PL (1) | PL200922B1 (pl) |
PT (1) | PT1229922E (pl) |
RU (1) | RU2261104C2 (pl) |
SI (1) | SI1229922T1 (pl) |
SK (1) | SK287762B6 (pl) |
WO (1) | WO2001035974A2 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148933A1 (en) | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
UA76718C2 (uk) | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
BR0114604A (pt) | 2000-10-12 | 2003-10-14 | Pharma Mar Sa | Tratamento de cnceres |
ES2315404T3 (es) * | 2001-10-19 | 2009-04-01 | Pharma Mar, S.A. | Uso de aplidina para el tratamiento de cancer de pancreas. |
DK1603584T3 (da) | 2003-03-12 | 2009-01-05 | Dana Farber Cancer Inst Inc | Aplidine til behandling af multipelt myelom |
US7576188B2 (en) * | 2003-03-12 | 2009-08-18 | Pharma Mar, S.A.U. | Antitumoral treatments |
RS54928B1 (sr) | 2006-02-28 | 2016-10-31 | Pharma Mar Sa | Poboljšano lečenje multiplog mijeloma |
ES2350803T3 (es) * | 2006-11-03 | 2011-01-27 | Nerviano Medical Sciences S.R.L. | Procedimiento de administración de un compuesto antitumoral. |
JP2011500650A (ja) * | 2007-10-19 | 2011-01-06 | ファルマ・マール・ソシエダード・アノニマ | 改良された抗腫瘍治療 |
WO2009111698A1 (en) * | 2008-03-07 | 2009-09-11 | Pharma Mar, S.A. | Improved anticancer treatments |
CN103463020B (zh) * | 2013-09-23 | 2015-11-25 | 李淑兰 | Lycojaponicumin A在制备治疗肾癌药物中的应用 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342744A (en) * | 1979-07-19 | 1982-08-03 | Lever Brothers Company | Hair treatment products |
DE3161556D1 (en) * | 1980-09-12 | 1984-01-05 | Univ Illinois | Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them |
US4493796A (en) * | 1980-09-12 | 1985-01-15 | Board Of Trustees, Univ. Of Ill. | Didemnins A, B, C, and derivatives thereof, as antiviral agents |
US4950649A (en) * | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
ATE74761T1 (de) * | 1985-09-20 | 1992-05-15 | Cernitin Sa | Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung. |
GB8922026D0 (en) * | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
US20030148933A1 (en) * | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
US5580871A (en) * | 1992-11-20 | 1996-12-03 | The Dupont Merck Pharmaceutical Company | 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity |
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
US5462726A (en) * | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
EP0739210B1 (en) * | 1993-12-29 | 2002-07-24 | Matrix Pharmaceutical, Inc. | Compositions for local delivery of cytostatic agents |
US5861439A (en) * | 1994-11-14 | 1999-01-19 | Alza Corporation | Method for enhanced electrotransport agent delivery |
US6365597B1 (en) * | 1996-02-14 | 2002-04-02 | Aventis Pharmaceuticals Inc. | 4-aza steroids |
CA2255615C (en) * | 1996-05-22 | 2006-08-29 | Neuromedica, Inc. | Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel |
US6156724A (en) * | 1996-06-07 | 2000-12-05 | Rinehart; Kenneth L. | Uses of didemnins as immunomodulating agents |
US6034058A (en) * | 1997-04-15 | 2000-03-07 | Rinehart; Kenneth L. | Semi-synthetic alanyl dilemnin analogs |
US6030943A (en) * | 1997-05-07 | 2000-02-29 | Crumb; William J. | Dehydrodidemnin B as an L-type calcium channel enhancer |
US6245759B1 (en) * | 1999-03-11 | 2001-06-12 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US20010021380A1 (en) * | 1999-04-19 | 2001-09-13 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
US6890904B1 (en) * | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
US6509315B1 (en) * | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
DE60123232T2 (de) * | 2000-04-07 | 2007-11-08 | Trustees Of The University Of Pennsylvania | Tamandarin und didemnin analoga und methoden zu deren herstellung und verwendung |
UA76718C2 (uk) * | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
AU1305302A (en) * | 2000-10-05 | 2002-04-15 | Immunex Corp | Nectin polypeptides, polynucleotides, methods of making and use thereof |
BR0114604A (pt) * | 2000-10-12 | 2003-10-14 | Pharma Mar Sa | Tratamento de cnceres |
AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
US6610399B1 (en) * | 2000-11-17 | 2003-08-26 | Structural Technologies, Llc | Multi-layer, thermal protection and corrosion protection coating system for metallic tendons, especially for external post-tensioning systems |
ES2315404T3 (es) * | 2001-10-19 | 2009-04-01 | Pharma Mar, S.A. | Uso de aplidina para el tratamiento de cancer de pancreas. |
DK1603584T3 (da) * | 2003-03-12 | 2009-01-05 | Dana Farber Cancer Inst Inc | Aplidine til behandling af multipelt myelom |
US7576188B2 (en) * | 2003-03-12 | 2009-08-18 | Pharma Mar, S.A.U. | Antitumoral treatments |
EP1613338A4 (en) * | 2003-03-21 | 2009-06-24 | Madeleine M Joullie | TAMANDARIN ANALOGUES, FRAGMENTS THEREOF AND METHODS OF MAKING AND USING THE SAME |
EP2003196A3 (en) * | 2003-06-09 | 2009-01-07 | The Regents of the University of Michigan | Compositions and methods for treating and diagnosing cancer |
RS54928B1 (sr) * | 2006-02-28 | 2016-10-31 | Pharma Mar Sa | Poboljšano lečenje multiplog mijeloma |
JP2011500650A (ja) * | 2007-10-19 | 2011-01-06 | ファルマ・マール・ソシエダード・アノニマ | 改良された抗腫瘍治療 |
-
2000
- 2000-11-15 AU AU14023/01A patent/AU780417B2/en not_active Ceased
- 2000-11-15 DK DK00976137T patent/DK1229922T3/da active
- 2000-11-15 SK SK659-2002A patent/SK287762B6/sk not_active IP Right Cessation
- 2000-11-15 KR KR10-2002-7006155A patent/KR100518986B1/ko not_active IP Right Cessation
- 2000-11-15 DE DE60035120T patent/DE60035120T2/de not_active Expired - Lifetime
- 2000-11-15 AT AT00976137T patent/ATE363910T1/de active
- 2000-11-15 MX MXPA02004862A patent/MXPA02004862A/es active IP Right Grant
- 2000-11-15 JP JP2001537965A patent/JP2003514025A/ja active Pending
- 2000-11-15 HU HU0203906A patent/HUP0203906A2/hu unknown
- 2000-11-15 ES ES00976137T patent/ES2288486T3/es not_active Expired - Lifetime
- 2000-11-15 SI SI200030960T patent/SI1229922T1/sl unknown
- 2000-11-15 CA CA002391502A patent/CA2391502A1/en not_active Abandoned
- 2000-11-15 EP EP00976137A patent/EP1229922B1/en not_active Expired - Lifetime
- 2000-11-15 CN CN00818404A patent/CN1423564A/zh active Pending
- 2000-11-15 PL PL355335A patent/PL200922B1/pl not_active IP Right Cessation
- 2000-11-15 RU RU2002115864/14A patent/RU2261104C2/ru not_active IP Right Cessation
- 2000-11-15 NZ NZ518847A patent/NZ518847A/en not_active IP Right Cessation
- 2000-11-15 WO PCT/GB2000/004349 patent/WO2001035974A2/en active Search and Examination
- 2000-11-15 IL IL14948800A patent/IL149488A0/xx unknown
- 2000-11-15 BR BR0015811-9A patent/BR0015811A/pt not_active Application Discontinuation
- 2000-11-15 CZ CZ20021697A patent/CZ302498B6/cs not_active IP Right Cessation
- 2000-11-15 PT PT00976137T patent/PT1229922E/pt unknown
-
2002
- 2002-05-14 NO NO20022293A patent/NO330719B1/no not_active IP Right Cessation
- 2002-05-18 BG BG106714A patent/BG65381B1/bg unknown
- 2002-09-25 HK HK02106981.6A patent/HK1045648B/zh not_active IP Right Cessation
-
2007
- 2007-08-30 CY CY20071101110T patent/CY1106825T1/el unknown
-
2008
- 2008-12-23 US US12/342,478 patent/US20090298752A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1229922T3 (da) | Aplidin-behandling af cancere | |
Wils | The treatment of advanced gastric cancer. | |
JP2022088662A5 (pl) | ||
AU5089799A (en) | Drug complex for treatment of metastatic prostate cancer | |
HK1131165A1 (zh) | 幫助調控血管生成、抑制轉移和腫瘤纖維化以及評估結腸癌腫瘤的惡性程度的藥物組合物及方法 | |
EP0284362A3 (en) | Molecular markers | |
DK1378240T3 (da) | Farmaceutiske præparater omfattende arsentrioxid til behandling af multipelt myelom | |
MX368013B (es) | Tratamiento de cáncer. | |
YU69903A (sh) | Postupak i dozni oblik za lečenje tumora primenom tegafura, uracila, folne kiseline, paklitaksela i karboplatina | |
TR200001687T2 (tr) | Neopleasyo için N-benzil-3-indenilasetamid türevleri. | |
BG108932A (en) | Pharmaceutical composition comprising arsenite for the treatment of malignancy | |
IL160382A0 (en) | Use of 4-pyridylmethylphthalazines for cancer treatment | |
ZA200106725B (en) | Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral antiparasitic or antitumoral cytotoxic response. | |
AU5302599A (en) | Method for diagnosing bone metastasis of malignant tumor | |
DK1140147T3 (da) | hCG-terapi til behandling af metastatisk brystcancer | |
AU1991901A (en) | Pharmaceutical composition for treating and preventing human tumors, which express the tumor antigen mucin and/or the carcinoembryonic antigen (cea), and the use thereof | |
ZA200203166B (en) | Treatment of cancer. | |
WO2004098651A3 (en) | Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy | |
MXPA04002407A (es) | Uso de 4-piridilmeetil-ftalazinas para el tratamiento de cancer. | |
AU2003267511A8 (en) | Use of pthrp antagonists for treating renal cell carcinoma | |
EP1465633A4 (en) | QUINAZOLINONE COMPOUNDS IN COMBINED FORMS FOR ENHANCED CANCER TREATMENT | |
WO2002081640A3 (en) | Gene shinc-1 and diagnostic and therapeutic uses thereof | |
NO924781L (no) | Heterocykliske antracyklion- og antracyklin-analoger |